prednisone has been researched along with Mast Cell Activation Disease in 5 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamm, CG | 1 |
| Stern, AW | 1 |
| Smith, AJ | 1 |
| Cooper, EJ | 1 |
| Ullom, SW | 1 |
| Campbell, GA | 1 |
| Rassnick, KM | 1 |
| Bailey, DB | 1 |
| Russell, DS | 1 |
| Flory, AB | 1 |
| Kiselow, MA | 1 |
| Intile, JL | 1 |
| Malone, EK | 1 |
| Balkman, CE | 1 |
| Barnard, SM | 1 |
| Feld, C | 1 |
| Spangenberger, H | 1 |
| Böhm, J | 1 |
| Meuthen, D | 1 |
| Meuthen, I | 1 |
| de las Nieves, M | 1 |
| Poveda, F | 1 |
| Queipo de Llano, MP | 1 |
| González-Hermoso, C | 1 |
| Hübner, C | 1 |
| Wedding, U | 1 |
| Sträter, J | 1 |
| Limberg, B | 1 |
| Stremmel, W | 1 |
1 trial available for prednisone and Mast Cell Activation Disease
| Article | Year |
|---|---|
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, | 2010 |
4 other studies available for prednisone and Mast Cell Activation Disease
| Article | Year |
|---|---|
Disseminated cutaneous mast cell tumors with epitheliotropism and systemic mastocytosis in a domestic cat.
Topics: Animals; Anti-Bacterial Agents; Cats; Exons; Female; Fetus; Mast Cells; Mastocytosis; Mastocytosis, | 2009 |
[76-year old patient with suspected but not confirmed "idiopathic myelofibrosis"].
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Humans; Male; Mastocytosis; Prednisone; Pri | 2011 |
[System mastocytosis: presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b].
Topics: Bone Marrow; Cerebral Hemorrhage; Combined Modality Therapy; Fatal Outcome; Female; Histamine Antago | 1997 |
Clinical stable systemic mastocytosis with interferon alpha-2b therapy.
Topics: Antineoplastic Agents; Disease Progression; Drug Therapy, Combination; Glucocorticoids; Humans; Inte | 1997 |